Management of bone density loss, as the result of calcium malabsorption in celiac disease, is critical in preventing premature bone fracture. As many of these patients need follow-up with primary care providers, internists are expected to be aware of screening and prompt management of osteopenia or osteoporosis in celiac disease. We present a case of a 32-year-old man with celiac disease who was diagnosed with osteoporosis. He was treated with calcium, vitamin D and alendronate which improved bone mineral density. This case illustrates the importance of using bisphosphonate in treating osteoporosis in celiac disease.

A study on the effect of ferrous sulfate liquid (lberet - 500 liquid) was conducted on a group of well-nourished children aged 6 months - 5 years.After 3 months 0/ treatment, hematological measurements revealed a statistically significant improvement as compared to the control group receiving placebo. Side effects were also found to be minimal. Thus ferrous sulfate liquid is recommended for treatment or supplement to anemia eradication, preferably associated with a high dose of vitamin C.